To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.
- Introduced Jun 14
- Committee Jun 14
- Passed House Next
- Passed Senate Not yet
- To President Not yet
- Law Not yet
Companies lobbying on this bill
1 companyVotes
No recorded roll-call vote on this bill yet
Member trades
No member of Congress traded these companies in the last 90 days
Summary
This bill requires state Medicaid programs to monitor (through their drug utilization review programs) the use of antipsychotic medications by adults, particularly individuals over the age of 65, individuals who receive home- and community-based services, and individuals who are in institutional care settings (e.g., nursing facilities). (States are currently only required to monitor the use of antipsychotic medications by children.)
Library of Congress summary, Jun 14, 2023
- Introduced in HouseJun 14, 2023
Actions
- HouseReferred to the Subcommittee on Health.Jun 16, 2023
- HouseIntroduced in HouseJun 14, 2023
- HouseReferred to the House Committee on Energy and Commerce.Jun 14, 2023
Bill record
Text versions1
- Introduced in HouseJun 14, 2023PDF: Introduced in House
Committees1
- House Energy and Commerce CommitteeReferred To Jun 14, 2023
- Subcommittee: Health SubcommitteeReferred to
Sponsor and cosponsors2 cosponsors
- Rep. Earl Carter (R-GA-1)Sponsor, Jun 14, 2023
- JANICE SCHAKOWSKY (D-IL-9)OriginalJoined Jun 14, 2023
- Rick Allen (R-GA-12)Joined Jun 16, 2023
Amendments0
No amendments offered
Cost estimates and reports0
No cost estimate or committee report yet
Titles1
- To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.Official Title as Introduced
Subjects6
Related bills0
No related bills listed
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.